Your browser is no longer supported. Please, upgrade your browser.
Settings
AEMD Aethlon Medical, Inc. daily Stock Chart
AEMD [NASD]
Aethlon Medical, Inc.
Index- P/E- EPS (ttm)-0.87 Insider Own1.50% Shs Outstand9.59M Perf Week-13.12%
Market Cap18.41M Forward P/E- EPS next Y- Insider Trans40.14% Shs Float7.19M Perf Month28.01%
Income-7.00M PEG- EPS next Q- Inst Own26.00% Short Float2.92% Perf Quarter-9.86%
Sales0.40M P/S46.03 EPS this Y-42.20% Inst Trans-2.31% Short Ratio1.02 Perf Half Y-42.69%
Book/sh-0.10 P/B- EPS next Y- ROA-703.10% Target Price26.00 Perf Year-59.83%
Cash/sh0.03 P/C61.38 EPS next 5Y- ROE- 52W Range1.34 - 5.40 Perf YTD-54.29%
Dividend- P/FCF- EPS past 5Y25.10% ROI-554.70% 52W High-64.44% Beta2.34
Dividend %- Quick Ratio0.90 Sales past 5Y-22.00% Gross Margin- 52W Low43.28% ATR0.29
Employees7 Current Ratio0.90 Sales Q/Q- Oper. Margin- RSI (14)51.92 Volatility14.42% 15.16%
OptionableNo Debt/Eq- EPS Q/Q24.10% Profit Margin- Rel Volume1.92 Prev Close1.75
ShortableYes LT Debt/Eq- EarningsAug 10 AMC Payout- Avg Volume206.37K Price1.92
Recom- SMA208.86% SMA507.62% SMA200-31.38% Volume397,271 Change9.41%
Sep-14-17 07:30AM  Aethlon Medical Receives National Cancer Institute Contract Award PR Newswire
Sep-13-17 08:20AM  Today's Research Reports on Stocks to Watch: Aldeyra Therapeutics and Aethlon Medical ACCESSWIRE -12.22%
Sep-12-17 07:30AM  Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier® as a Treatment for Life-Threatening Viruses PR Newswire +35.13%
Sep-11-17 08:51PM  Should You Have Aethlon Medical Incs (AEMD) In Your Portfolio? Simply Wall St. +25.67%
Sep-06-17 09:12AM  Aethlon Medical to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 11, 2017 PR Newswire +7.38%
Aug-21-17 10:00AM  AEMD: EAP Filed, Expect FDA Response By Mid-September Zacks Small Cap Research
Aug-11-17 09:02AM  Former NFL Pro Supports Study Of Brain Injuries And Dementia In Football Forbes
Aug-10-17 04:15PM  Aethlon Medical Announces Fiscal 2018 First Quarter Results PR Newswire -10.56%
01:00PM  Investor Network: Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE
Aug-03-17 07:29PM  ETFs with exposure to Aethlon Medical, Inc. : August 3, 2017 Capital Cube
08:00AM  Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2018 and Host Conference Call on August 10, 2017 PR Newswire
Jul-19-17 07:11AM  Aethlon Medical Announces the Grant of a U.S. Patent Protecting Methods of Capturing MHC Antigen Associated Exosomes PR Newswire
Jul-07-17 07:00AM  Corporate News Blog - MedShape Divests its ExoShape(R) ACL Product Line to CONMED Accesswire
Jul-03-17 02:46PM  ETFs with exposure to Aethlon Medical, Inc. : July 3, 2017 Capital Cube
Jun-30-17 03:00PM  AEMD: Feasibility Study Validates Capture, EAP FDA Filing Is Next Zacks Small Cap Research
12:50PM  Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: 2017 By the Numbers : June 30, 2017 Capital Cube
Jun-28-17 04:15PM  Aethlon Medical Announces Fiscal 2017 Results PR Newswire +10.23%
Jun-26-17 08:15AM  Aethlon Medical To Release 2017 Fiscal Year End Financial Results and Host Conference Call on June 28, 2017 PR Newswire
Jun-14-17 08:00AM  Aethlon Medical To Present Clinical Study Results at The BIO International Convention PR Newswire +50.00%
Jun-06-17 08:00AM  Aethlon Medical, Inc., Announces Upcoming Presentation and Webcast at the LD Micro Invitational Conference on June 6, 2017 PR Newswire
May-24-17 08:00AM  Aethlon to Present at the LD Micro Invitational Conference on June 6, 2017 PR Newswire -6.24%
Apr-28-17 11:00AM  AEMD: Feasibility Study Complete. FDA Discussions Expected To Follow Zacks Small Cap Research
Apr-24-17 09:25AM  Aethlon Medical Releases Shareholder Update PR Newswire
Apr-04-17 09:03AM  Aethlon Medical Discloses Tech Nation Interview On National Public Radio PR Newswire -19.47%
09:03AM  Aethlon Medical Discloses Tech Nation Interview On National Public Radio
Mar-31-17 09:17AM  AETHLON MEDICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of
Mar-21-17 02:50PM  AETHLON MEDICAL INC Files SEC form 8-K, Other Events
Mar-14-17 05:17PM  AETHLON MEDICAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +6.59%
Mar-13-17 07:15AM  Aethlon Medical Announces The Conclusion Of Hemopurifier Clinical Study PR Newswire +31.74%
Mar-08-17 09:25AM  Aethlon Medical To Present At ROTH Capital Partners 29th Annual Growth Stock Conference On March 14, 2017 PR Newswire
Mar-01-17 09:25AM  Aethlon Medical Announces the Grant of a European Patent Protecting Methods of Quantifying Exosomes PR Newswire
Feb-24-17 09:25AM  Aethlon Medical CEO Note: Bill Gates on the Threat of Bioterrorism PR Newswire
Feb-22-17 09:25AM  Aethlon Medical Reports Results of Cytomegalovirus, Epstein-Barr and Herpes Simplex Virus Studies PR Newswire
Feb-16-17 01:04PM  AETHLON MEDICAL INC Financials
Feb-15-17 09:00AM  AEMD: FDA Discussions Regarding U.S. Clearance Pathway Zacks Small Cap Research
09:00AM  AEMD: FDA Discussions Regarding U.S. Clearance Pathway
Feb-10-17 05:18PM  AETHLON MEDICAL INC Files SEC form 10-Q, Quarterly Report -9.62%
04:15PM  Aethlon Medical Announces Fiscal 2017 Third Quarter Results PR Newswire
07:07AM  Q3 2017 Aethlon Medical Inc Earnings Release - After Market Close
Feb-07-17 04:16PM  AETHLON MEDICAL INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standar
Feb-06-17 09:25AM  Aethlon Medical To Host Third Quarter Fiscal 2017 Investor Call On February 10, 2017 PR Newswire
Jan-27-17 11:00AM  AEMD: New CTE Study Largest in Ex-NFL Players
Jan-25-17 09:41AM  Aethlon Medical Inc. (AEMD) Readies CTE Blood Diagnostic Trial As Super Bowl LI Approaches at Insider Monkey
07:00AM  Researchers Announce Plans for Study of Candidate Blood Test to Detect Chronic Traumatic Encephalopathy (CTE) in Former NFL Players PR Newswire
Jan-20-17 12:43PM  ETFs with exposure to Aethlon Medical, Inc. : January 20, 2017
Jan-11-17 09:12AM  CEO Note - Clinical Study Update and a Review of 2016 Accomplishments PR Newswire
Jan-03-17 12:21PM  ETFs with exposure to Aethlon Medical, Inc. : January 3, 2017
Dec-30-16 03:06PM  AETHLON MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob
Dec-22-16 12:46PM  ETFs with exposure to Aethlon Medical, Inc. : December 22, 2016
Dec-21-16 09:25AM  Passage of the 21st Century Cures Act and its Potential Implications on Biodefense PR Newswire
Dec-15-16 09:25AM  Aethlon Announces Initiation of Sepsis-Related Virus Study PR Newswire
Dec-08-16 02:09PM  ETFs with exposure to Aethlon Medical, Inc. : December 8, 2016
Nov-16-16 12:33PM  ETFs with exposure to Aethlon Medical, Inc. : November 16, 2016 -9.00%
Nov-14-16 11:52AM  Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: Q2, 2017 By the Numbers : November 14, 2016
Nov-10-16 05:18PM  AETHLON MEDICAL INC Files SEC form 10-Q, Quarterly Report
04:15PM  Aethlon Medical Announces Fiscal 2017 Second Quarter Results PR Newswire
07:07AM  Q2 2017 Aethlon Medical Inc Earnings Release - After Market Close
Nov-03-16 09:25AM  Aethlon Medical To Host Second Quarter Fiscal 2017 Investor Call On November 10, 2016 PR Newswire
Nov-01-16 01:21PM  Aethlon Medical, Inc. (AEMD) Approaching A Major Catalyst With Hemopurifier Trial at Insider Monkey
Oct-13-16 09:11AM  Aethlon Medical Achieves DARPA Milestones, Including Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Validation PR Newswire
Oct-12-16 09:25AM  Aethlon Medical Announces Corporate Update Presentation At Next Week's 2016 Bio Investor Forum PR Newswire
Sep-20-16 09:25AM  Aethlon Medical Updates Corporate Presentation Schedule PR Newswire
Sep-12-16 09:25AM  Aethlon Medical To Present At The Rodman & Renshaw 18th Annual Global Investment Conference On September 13, 2016 PR Newswire
Sep-09-16 09:09AM  The Dilemma in Funding Zika and Other Pandemic Therapies PR Newswire
Sep-06-16 09:25AM  Aethlon Medical Announces Upcoming September Investor And Industry Conferences PR Newswire
Aug-22-16 12:20PM  Edited Transcript of AEMD earnings conference call or presentation 11-Aug-16 8:30pm GMT
Aug-18-16 10:20AM  AEMD: Q1 Results. Add Zika to List of Potential Targets -10.83%
Aug-11-16 05:18PM  AETHLON MEDICAL INC Files SEC form 10-Q, Quarterly Report +23.40%
04:15PM  Aethlon Medical Announces Fiscal 2017 First Quarter Results PR Newswire
01:05PM  5 Biohealth Stocks Rising 10% or More on News at 24/7 Wall St.
09:12AM  Aethlon Medical Announces Zika Virus Data PR Newswire
07:07AM  Q1 2017 Aethlon Medical Inc Earnings Release - Time Not Supplied
Aug-10-16 03:02PM  AETHLON MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal
Aug-09-16 12:07PM  Aethlon Medical To Host First Quarter Fiscal 2017 Investor Call On August 11, 2016 PR Newswire
Jul-26-16 09:27AM  Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016
Jul-20-16 12:06PM  ETFs with exposure to Aethlon Medical, Inc. : July 20, 2016
Jul-06-16 10:11AM  Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: Q4, 2016 By the Numbers : July 6, 2016
Jul-05-16 09:45AM  AEMD: U.S. Clinical Trial Progressing, ATM Financing
Jun-30-16 11:44AM  Edited Transcript of AEMD earnings conference call or presentation 29-Jun-16 8:30pm GMT
Jun-29-16 05:18PM  AETHLON MEDICAL INC Files SEC form 10-K, Annual Report +6.79%
04:15PM  Aethlon Medical Announces Fiscal 2016 Results PR Newswire
07:07AM  Q4 2016 Aethlon Medical Inc Earnings Release - Time Not Supplied
Jun-28-16 09:15AM  Aethlon Medical Announces $12.5 Million At The Market Program PR Newswire
08:16AM  AETHLON MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secur
Jun-27-16 09:45AM  Aethlon Medical Joins Russell Microcap® Index PR Newswire
09:15AM  Aethlon Medical to Host Fourth Quarter and Full Year Fiscal 2016 Investor Call On June 29, 2016 PR Newswire
Jun-22-16 09:15AM  Aethlon Medical Set To Join Russell Microcap® Index PR Newswire +6.70%
Jun-14-16 10:28AM  Aethlon Medical Announces Issuance Of Exosome Capture Patent PR Newswire +10.02%
Jun-07-16 02:04PM  AETHLON MEDICAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jun-06-16 09:30AM  Aethlon Medical To Present Cancer And Infectious Disease Initiatives, As Well As Chronic Traumatic Encephalopathy (CTE) Candidate Biomarker Discovery At Tomorrow's BIO International Convention PR Newswire +8.21%
Jun-03-16 02:04PM  AETHLON MEDICAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jun-01-16 09:30AM  Aethlon Medical To Present At 2nd Annual Sachs Associates Immuno-oncology: BD&L And Investment Forum On June 3, 2016 PR Newswire
May-25-16 04:00PM  AEMD: U.S. Study Progressing. Zika May Offer Another Opportunity
May-19-16 08:45AM  4 Companies That May Benefit From the Rio Olympic Games at 24/7 Wall St.
May-05-16 09:00AM  Aethlon Medical's CEO and Executive Chairman James Joyce Interviewed by The Life Sciences Report Marketwired
May-04-16 09:30AM  Aethlon Medical's Exosome Sciences Announces Production of ELLSA Exosome Isolation Platform PR Newswire
May-02-16 08:45AM  Aethlon Medical (AEMD) CEO Note: Hemopurifier Clinical Progression, USA Today on the Next Zika, Combating Bioterror & Pandemic Threats PR Newswire +6.17%
Apr-05-16 09:00AM  FinancialBuzz.com Exclusive NASDAQ MarketSite Interview with Aethlon Medical, Inc. CEO James Joyce PR Newswire
Mar-31-16 09:30AM  Aethlon Medical Discloses Hemopurifier® Clinical Trial and Manufacturing Advancements PR Newswire
Mar-30-16 06:09PM  AETHLON MEDICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of +5.14%
Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device for the single-use removal of life-threatening viruses from the circulatory system of infected individuals. It is also involved in the development of exosome-based products to diagnose and monitor neurological disorders and cancer; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection. The company was founded in 1991 and is based in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Champion Christopher OSVP, CAO and ControllerJun 01Option Exercise0.001,49104,267Jun 05 04:23 PM
CHASE ANTHONY RDirectorMay 18Buy52.481,90599,96723,636May 18 04:27 PM
WALKER R AChairman, President & CEOMay 17Buy51.8219,3001,000,213176,718May 17 05:25 PM
FLUOR PETER JDirectorMay 17Buy51.8320,0001,036,556146,750May 17 05:22 PM
GORDON JOHN RDirectorMay 11Option Exercise47.203,950186,440180,375May 12 04:37 PM
Hollek Darrell EEVP, OperationsApr 27Option Exercise0.0025,762040,723May 01 05:33 PM
GORDON JOHN RDirectorNov 11Sale61.307,500459,750171,079Nov 15 04:54 PM
GORDON JOHN RDirectorNov 10Option Exercise47.977,500359,775178,579Nov 15 04:54 PM
WALKER R AChairman, President & CEONov 06Option Exercise0.0019,8200161,545Nov 07 06:14 PM
Hollek Darrell EEVP, U.S. Onshore Expl./Prod.Nov 06Option Exercise0.003,146015,375Nov 07 06:13 PM
GWIN ROBERT GEVP, Finance & CFONov 06Option Exercise0.007,9120112,617Nov 07 06:10 PM
DANIELS ROBERT PEVPNov 06Option Exercise0.008,091041,339Nov 07 06:08 PM
REEVES ROBERT KEVP, Law & CAONov 06Option Exercise0.006,1930115,530Nov 07 06:06 PM
Leyendecker Ernest A. IIIEVP, Intl./Deepwater Expl.Nov 06Option Exercise0.002,605017,806Nov 07 06:04 PM
Ingram Mitchell WEVP, Global LNGNov 01Option Exercise0.0019,937020,030Nov 02 05:06 PM
WALKER R AChairman, President & CEOOct 26Option Exercise0.0013,4030151,220Oct 27 07:32 PM
Leyendecker Ernest A. IIIEVP, Intl./Deepwater Expl.Oct 26Option Exercise0.001,933016,023Oct 27 07:29 PM
DANIELS ROBERT PEVPOct 26Option Exercise0.005,496037,133Oct 27 07:26 PM
GWIN ROBERT GEVP, Finance & CFOOct 26Option Exercise0.005,3750108,503Oct 27 07:24 PM
Champion Christopher OVP, CAO and ControllerOct 26Option Exercise0.001,69103,212Oct 27 07:21 PM
REEVES ROBERT KEVP, Law & CAOOct 26Option Exercise0.004,1910112,303Oct 27 07:18 PM